Topco Scientific Co.,Ltd. (TPE:5434)

Topco Scientific Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	63,863	54,768	46,944	50,555	41,098	35,233
Other Revenue	2,329	2,229	2,329	2,423	1,571	934.93
Revenue	66,192	56,997	49,273	52,978	42,669	36,168
Revenue Growth (YoY)	24.13%	15.68%	-6.99%	24.16%	17.97%	14.09%
Cost of Revenue	57,787	49,279	42,855	46,453	37,457	31,863
Gross Profit	8,405	7,718	6,419	6,525	5,212	4,305
Selling, General & Admin	4,008	3,712	3,091	3,139	2,559	2,143
Research & Development	62.03	66.64	117.48	156.41	101.17	100.23
Other Operating Expenses	-1.29	-4.26	12.02	-0.29	-0.29	-0.29
Operating Expenses	4,068	3,775	3,221	3,296	2,660	2,243
Operating Income	4,337	3,943	3,198	3,230	2,552	2,062
Interest Expense	-95.7	-113.68	-99.57	-53.11	-34.23	-27.17
Interest & Investment Income	162.18	159.92	190.85	122.91	60.98	59.38
Earnings From Equity Investments	542.09	609.81	471.82	541.72	422.68	373.35
Currency Exchange Gain (Loss)	-8.45	-8.45	-13.74	123.55	-38.39	-44.91
Other Non Operating Income (Expenses)	110.54	95.35	78.86	54.96	50.18	34.93
EBT Excluding Unusual Items	5,047	4,686	3,826	4,020	3,013	2,457
Merger & Restructuring Charges	-	-	-	-	-0.12	-
Gain (Loss) on Sale of Investments	83.76	83.76	80.15	248.5	45.27	7.6
Gain (Loss) on Sale of Assets	-10.25	-10.25	-26.11	-26.65	-8.53	94.55
Asset Writedown	-30.4	-30.4	-	-	-10.03	-
Pretax Income	5,090	4,729	3,880	4,242	3,040	2,559
Income Tax Expense	1,199	1,064	1,028	1,167	738.89	494.1
Earnings From Continuing Operations	3,891	3,665	2,853	3,075	2,301	2,065
Minority Interest in Earnings	-10.34	-9.16	-17.89	-56.7	-6.5	3.03
Net Income	3,881	3,656	2,835	3,018	2,294	2,068
Net Income to Common	3,881	3,656	2,835	3,018	2,294	2,068
Net Income Growth	15.30%	28.96%	-6.08%	31.55%	10.93%	20.09%
Shares Outstanding (Basic)	191	190	185	182	182	182
Shares Outstanding (Diluted)	196	195	189	184	183	183
Shares Change (YoY)	0.19%	3.29%	2.84%	0.48%	-0.09%	0.23%
EPS (Basic)	20.29	19.29	15.36	16.61	12.63	11.38
EPS (Diluted)	19.90	18.78	15.03	16.41	12.53	11.29
EPS Growth	14.96%	24.93%	-8.39%	30.97%	10.98%	19.85%
Free Cash Flow	5,080	866.68	-152.61	2,815	2,191	1,734
Free Cash Flow Per Share	25.95	4.44	-0.81	15.30	11.97	9.46
Dividend Per Share	12.000	12.000	10.000	10.000	8.800	8.000
Dividend Growth	20.04%	20.00%	-	13.64%	10.00%	23.08%
Gross Margin	12.70%	13.54%	13.03%	12.32%	12.21%	11.90%
Operating Margin	6.55%	6.92%	6.49%	6.10%	5.98%	5.70%
Profit Margin	5.86%	6.41%	5.75%	5.70%	5.38%	5.72%
Free Cash Flow Margin	7.67%	1.52%	-0.31%	5.31%	5.14%	4.79%
EBITDA	4,644	4,261	3,526	3,547	2,816	2,269
EBITDA Margin	7.02%	7.48%	7.16%	6.69%	6.60%	6.28%
D&A For EBITDA	307.53	318.03	327.86	316.89	263.9	207.72
EBIT	4,337	3,943	3,198	3,230	2,552	2,062
EBIT Margin	6.55%	6.92%	6.49%	6.10%	5.98%	5.70%
Effective Tax Rate	23.55%	22.50%	26.48%	27.50%	24.31%	19.30%
Revenue as Reported	66,192	56,997	49,273	52,978	42,669	36,168

Source: S&P Global Market Intelligence. Standard template. Financial Sources.